William Anderson Wittekind - 30 Jun 2018 Form 5 Insider Report for Enochian Biosciences Inc (RENB)

Role
10%+ Owner
Signature
/s/ William Anderson Wittekind
Issuer symbol
RENB
Transactions as of
30 Jun 2018
Net transactions value
-$1,600,000
Form type
5
Filing time
06 Feb 2023, 18:26:09 UTC
Next filing
06 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Sale $1,600,000 -200,000 -1.1% $8.00* 17,545,283 21 Feb 2018 Weird Science LLC F1, F2, F3
holding RENB Common Stock 200,000 30 Jun 2018 Gumrukcu Health, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold by Gumrukcu Health, LLC, of which the Reporting Person is a minority managing member. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 These shares were issued to Weird Science LLC as merger consideration in exchange for common stock of Enochian BioPharma, Inc. (the "Target"), which the Issuer acquired by merger on February 16, 2018 pursuant to an Agreement and Plan of Merger dated January 12, 2018 by and among the Issuer, the Issuer's Merger Sub, the Target and Weird Science LLC (the "Merger Agreement").
F3 The Reporting Person is a manager of Weird Science LLC.
F4 This Form 5 amends the Form 3 filed by the Reporting Person on September 14, 2018 to include the 200,000 shares held by Gumrukcu Health, LLC as of February 16, 2018, the closing date under the Merger Agreement.